Skip to main content
What makes Aservo® EquiHaler® sustainable?
sustainable mobile
Veterinary Pharmaceutical Recycling Programme

The first veterinary pharmaceutical recycling programme is here*…

1.  Request a collection box from your BI Territory Manager

2.  Create a TerraCycle® account and register your practice by filling out the participation form at terracycle.com/aservo-equihaler-uk

3.  Owners return used Aservo® EquiHalers® to the practice

4.  Download a free shipping label from your TerraCycle® account and send your Aservo® EquiHaler® when your collection box is full

5.  Improve sustainability for your practice by reducing plastic waste and greenhouse gas emissions

 
*The Aservo® EquiHaler® recycling programme is only available in the UK

References

  1. Dalby, R., Spallek, M. and Voshaar, T. (2004) ‘A review of the development of Respimat® Soft Mist Inhaler’, International Journal of Pharmaceutics, 283(1-2), pp.1-9.
  2. Lavoie, J.P. et al. (2019) ‘Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction’, Equine Veterinary Journal, 51, pp. 779-786.
  3. CVMP assessment report for Aservo® EquiHaler®.
  4. Mukker,J.K., Singh, R.S.P. and Derendorf, H. (2016) 'Ciclesonide: a pro-soft drug approach for mitigation of side effects of inhaled corticosteroids', Journal of Pharmaceutical Sciences, 105, pp. 2509-2514.
  5. Hänsel, M., Bambach, T. and Wachtel, H. (2019) ‘Reduced Environmental Impact of the Reusable Respimat® Soft Mist™ Inhaler Compared with Pressurised Metered-Dose Inhalers’, Advances in therapy, 36(9), pp.2487-2492.
  6. Capstick, T.G.D. and Clifton, I.J. (2012) ‘Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma’, Expert Review of Respiratory Medicine, 6(1), pp. 91-103.
  7. Eicher, J et al (2011) Development of Respimat Soft Mist™ inhaler and its clinical utility in respiratory disorders, Medical Devices (Auckland) 4 pp145-155.
  8. Pirie, R.S. and McGorum, B.C. (2017) Inhalation therapy for equine lower respiratory tract disease In Practice, 39(7) pp317-327.

 

Aservo® EquiHaler® 343 micrograms/actuation inhalation solution for horses contains ciclesonide. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email:vetenquiries@boehringer-ingelheim.com. Aservo® EquiHaler® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: October 2023. UI-EQU-0119-2020. Use Medicines Responsibly.

Breathe Easy

There is a new way to treat severe equine asthma.

Aservo® EquiHaler® is a prescription only medicine. This site is provided as an information service for veterinary professionals and owners of horses prescribed Aservo® EquiHaler® by a Veterinary Surgeon. Please tick ‘I’m a veterinary professional’ to confirm that you are a veterinary professional (e.g. veterinary surgeon, veterinary nurse or veterinary student) or ‘My horse has been prescribed Aservo® EquiHaler®’ to continue.

Not a veterinarian? Go back to the Boehringer Ingelheim equine information page.